Article
Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics - 1 Feb 2024
Yang Ye, Wu Su Fang, Bao Wei
Abstract excerpt
BACKGROUND: When determining adjuvant treatment for endometrial cancer, the decision typically relies on factors such as cancer stage, histologic grade, subtype, and a few histopathologic markers. The Cancer Genome Atlas revealed molecular subtyping of endometrial cancer, which can provide more accurate prognostic information and guide personalized treatment plans. OBJECTIVE: To summarize the expression and...
Topics
- Female
- Humans
- Poly-ADP-Ribose Binding Proteins
- Mutation
- Endometrial Neoplasms
- Prognosis
- Neoplasm Staging
- Biomarkers, Tumor
